We came across a bullish thesis on Bristol-Myers Squibb Company (BMY) on Disruptive analytics’ Substack by Magnus Ofstad. In ...

We recently published a list of Jim Cramer Breaks Silence On DeepSeek AI Sell-Off & Discusses These 12 Stocks.

In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against the other stocks Jim Cramer recently discussed. In a recent appearance on CNBC’s ...

Bristol Myers (BMY) new psychiatric drug Cobenfy is effective in treating schizophrenia without “the serious side effects’ of other older therapies, writes Julie Coleman for CNBC..Bristol ...

But Alzheimer's is the "really large market here," Bristol Myers Squibb CFO David Elkins told CNBC on Tuesday at the JPMorgan Health Care Conference in San Francisco. There are nearly 6 million ...

In a recent appearance on CNBC’s Squawk on the Street ... ITCI)’s product portfolio: “Because Bristol-Myers currently has Cobenfy, that’s just been approved, FDA, exactly for some of ...

Bristol Myers Squibb CEO Chris Boerner described his company's new drug, Cobenfy, which can be used to treat psychiatric disorders like schizophrenia. He said the treatment is effective but doesn ...

In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE ... In an interview with CNBC on January 16, Christopher Waller, Governor of the Federal Reserve, discussed ...

We recently compiled a list of the 15 Stocks to Invest in with Steady Dividends. In this article, we are going to take a look ...